SHC Sotera Health

Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators

Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators

New Nelson Labs Mark offers transparency and confidence in product testing

SALT LAKE CITY, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Nelson Labs, a leading global provider of laboratory testing and expert advisory services, announced today that it has launched the Nelson Labs Mark, a verification program for product testing that authenticates test reports and provides reliable data on product performance. The new offering empowers consumers to make informed decisions when purchasing face masks and respirators and provides credible manufacturers with the means to differentiate their products from others on the market.

Amidst a rise in fraudulent products and a surge in COVID-19 cases, Nelson Labs anticipates the program will become a valuable tool for hospitals, municipalities, and commercial buyers, along with private consumers. The Nelson Labs Mark will begin with testing verification for masks and respirators but will expand to other products as the market requires.

“With varying regulatory requirements and amended qualifications during COVID-19, it is difficult for today’s consumers to discern legitimate products from those that have not been adequately tested,” said Jeffery R. Nelson, Chairman, Nelson Labs. “The Nelson Labs Mark addresses this critical need for increased transparency by providing objective, verifiable performance data from our world-class laboratories.”

To further increase consumer confidence, the Nelson Labs Mark includes two-factor authentication for consumers to easily confirm the legitimacy of a product’s testing. The Company will allow manufacturers participating in the Nelson Labs Mark program, whose products have undergone testing at Nelson Labs, to use the Nelson Labs Tested™ or Nelson Labs Verified™ mark on applicable product packaging and marketing, along with a corresponding web listing that includes detailed test reports outlining the performance of that product.

The Nelson Labs Mark will help credible manufacturers stand out from the crowd and build trust through transparency. This new service, combined with world-class testing and expert advisory services, will help Nelson Labs, a Sotera Health company, further deliver on its mission of Safeguarding Global Health®.

Learn more at .

About Nelson Labs: is a global leader in outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. Nelson Labs serves over 3,800 customers across 15 facilities in the United States, Mexico, Asia, and Europe. We have a comprehensive array of over 800 laboratory tests supporting our customers from initial product development and sterilization validation, through regulatory approval and ongoing product testing for sterility, safety, and quality assurance. We are regarded as a best-in-class partner with a strong track record of collaborating with customers to solve complex issues.

Safeguarding Global Health® - with every test we complete.

Media Contact

NELSON LABS:

Paul Huish

Sr. Director Global Marketing

801-290-7500



EN
09/02/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sotera Health

 PRESS RELEASE

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Pro...

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook 2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 20242025 Adjusted EBITDA(1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis2025 Adjusted EPS(1) of $0.86, an increase of $0.16 per diluted share, compared to 2024Full-year 2026 outlook: net revenues growth of 5.0% to 6.5% an...

 PRESS RELEASE

Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Rel...

Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date CLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2025 before the market opens on Tuesday, February 24, 2026. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s ...

 PRESS RELEASE

Sotera Health Appoints Richard Kyle to the Board of Directors

Sotera Health Appoints Richard Kyle to the Board of Directors CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today it has appointed Richard G. Kyle as a new independent director to its Board of Directors. Mr. Kyle will serve as a member of the Leadership Development and Compensation Committee and the Nominating and Corporate Governance Committee of the Board of Directors. Most recently, Mr. Kyle serve...

 PRESS RELEASE

Sotera Health to Showcase Continued Revenue Growth and Strategic Value...

Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, is presenting today at the 44th Annual J.P. Morgan Healthcare Conference. During the presentation, Management will be providing an update on Sotera Health’s business. “Sotera Health continued its solid g...

 PRESS RELEASE

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Con...

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. Company representatives will also participate in investor meetings during th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch